DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the TARSONS PRODUCTS LIMITED (TARSONS) share price today?

TARSONS PRODUCTS LIMITED (TARSONS) is trading at ₹287.45 on the NSE, down 4.02% on the day. Source: DocStoX.

What is the PE ratio of TARSONS PRODUCTS LIMITED?

TARSONS PRODUCTS LIMITED has a price-to-earnings (PE) ratio of 106.9 in the Healthcare sector.

What is the market capitalisation of TARSONS PRODUCTS LIMITED?

TARSONS PRODUCTS LIMITED has a market capitalisation of approximately ₹1,552 crore.

TARSONS PRODUCTS LIMITED

TARSONS·NSE·Healthcare

₹287.45▼ -12.05 (-4.02%)

Healthcare · Medical Equipment

A steady, established business

Day₹285.55

₹302.10

52W₹164

₹39454%

Open

₹300.00

High

₹302.10

Low

₹285.55

Prev Close

₹299.50

Volume

1.23L

VWAP

₹288.97

Snapshot

Key fundamentals

Market Cap

₹1,552 Cr

P/E Ratio

106.86Expensive

P/B Ratio

2.23

EPS

₹2.69

Book Value

₹119.00

ROE

2.38%Weak

ROCE

5.00%Weak

Dividend Yield

0.69%

Debt / Equity

0.62Moderate

Face Value

₹2.00

52W High

₹393.75

52W Low

₹164.45

Sector

Healthcare

Industry

Medical Equipment

Avoid

Narrow moatMedium uncertainty

Fair value estimate

₹80

▼ 72.3%downside

Trading at ₹287 — 72% above our estimate

BearFair valueBull

₹68₹80₹91

/100

Business quality — Watch the fundamentals

Growth 29Profitability 4Efficiency 0Valuation 35

Plain English

Our view

A steady, established business
Weak returns on equity (2%)

Risks

Weak returns on equity (2%)
Expensive — trades at 107× earnings
Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

2% ROE fading to 13% over ~10 yrs, on ₹119 book

₹78

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹85

Analyst target

No analyst coverage

—

Blended fair value₹80

What the numbers say

Investment thesis

Bull case

No standout positives from the current metrics.

Bear case

Weak returns on equity (2%)
Expensive — trades at 107× earnings
Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

106.9Expensive

Below 15× is value territory; above 35× prices in strong growth

ROE

2.4%Weak

Above 15% is considered healthy for Indian equities

ROCE

5.0%Weak

Above 18% means capital is working hard

Debt/Eq

0.62Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹1,552 Cr

P/B

2.23

EPS

₹2.69

Div Yield

0.69%

What changed

Recent changes

Foreign investors-1.6% stake last quarter
Domestic institutions+0.2% stake last quarter

What matters

News impact

Overview

Valuation

Expensive

P/E 106.9×

Growth

Steady

+14% rev CAGR

Profitability

Modest

2.4% ROE

Financial health

Comfortable

D/E 0.62

Momentum

N/A

No technicals

Today

Trading activity

Delivery %53.5%

Turnover₹355.51L Cr

Trades3,178

VWAP₹288.97

Face value₹2.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+14.3%

+13.1%

10Y

—

Profit

-44.2%

-27.3%

10Y

—

EPS

—

-76.3%

10Y

—

Profile

Cons

Stock is trading at 2.54 times its book value
Though the company is reporting repeated profits, it is not paying out dividend
Company has a low return on equity of 4.68% over last 3 years.
Company might be capitalizing the interest cost

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Foreign investors sold 1.60 pts; domestic institutions added 0.19 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

47%

Promoter

Promoters

47.3%0.00

Public

21.5%+1.21

FII / FPI

0.9%-1.60

DII

0.2%+0.19

Others

30.1%

Total shareholders

84,093-3,243 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter47.30%

FII0.87%

DII0.19%

Public21.54%

Others30.10%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions